Igor Shuryak

Columbia University Irving Medical Center

Papers

2

Total Citations

87

H-Index

2

About

Igor Shuryak is a leading researcher in radiation biodosimetry, whose work focuses on developing and validating high-throughput assays to measure DNA damage from complex radiation exposures. His major contributions include advancing the γ-H2AX assay for automated processing in human lymphocytes, a sensitive method for quantifying DNA double-strand breaks that is highly linear with radiation dose. This well-established biomarker, detailed in his 2010 paper (77 citations), has become a cornerstone for radiation biodosimetry. Shuryak has also validated the dicentric chromosome assay for complex exposures, such as those from nuclear weapons, simulating DNA damage effects beyond conventional orthovoltage irradiators (2022, 10 citations). His research bridges technological innovation and practical application, enhancing the accuracy and speed of radiation dose assessment for accidental or intentional exposures. By adapting these assays for high-throughput processing, Shuryak has significantly improved emergency response capabilities, making his work invaluable for both clinical and environmental radiation protection. His achievements underscore a commitment to translating laboratory methods into real-world tools for assessing human health risks from radiation.

Research Focus

Key Achievements

2
H-Index
2
Papers
87
Total Citations
44
Avg Citations/Paper
🏆 Most Cited Paper
Adapting the γ-H2AX Assay for Automated Processing in Human Lymphocytes. 1. Technological Aspects
77 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Columbia University Irving Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago